PATENT CLAIM ANALYSIS

Application Number: 15962673
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["424", "139100"]

Abstract:
The present disclosure provides antibodies that specifically bind to human glucocorticoid-induced TNFR family related receptor (GITR) and compositions comprising such antibodies. In a specific aspect, the antibodies specifically bind to human GITR and modulate GITR activity, e.g., enhance, activate or induce GITR activity, utilizing such antibodies. The present disclosure also provides methods for treating disorders, such as cancer and infectious diseases, by administering an antibody that specifically binds to human GITR and modulates GITR activity e.g., enhances, activates or induces GITR activity.

Claim (Index 235):
The host cell of  claim 227 , wherein first nucleic acid further encodes a human immunoglobulin IgG 1  heavy chain constant region and wherein second nucleic acid further encodes a human immunoglobulin IgG kappa light chain constant region.

Metadata:
- Claim Count in Document: 135.0
- Percentile: 91.0
- Lexical Diversity: 1.74545
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14724452', '14472116', '15714585', '11389880', '15517867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.803552699376977
- 35 USC 102 Novelty (BERT): 0.6086352606568275
- Combined Prediction Score: 0.7840609555049621
- Mean Citation Score: 479.718714
- Max Citation Score: 626.9613
- Similarity Product: 465.4453380664231

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test